ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) | |||
(Address of principal executive offices) |
(Zip Code) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
one-half of oneredeemable warrant |
The | |||
$0.0001 per share |
The | |||
The |
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
Auditior |
Auditor Name: |
Auditor Location: | ||
PCAOB ID |
Page |
||||||
Part I |
||||||
Item 1. | 1 | |||||
Item 1A. | 15 | |||||
Item 1B. | 18 | |||||
Item 2. | 18 | |||||
Item 3. | 18 | |||||
Item 4. | 18 | |||||
Part II |
||||||
Item 5. | 19 | |||||
Item 6. | 20 | |||||
Item 7. | 20 | |||||
Item 7A. | 25 | |||||
Item 8. | 25 | |||||
Item 9. | 25 | |||||
Item 9A. | 25 | |||||
Item 9B. | 27 | |||||
Part III |
||||||
Item 10. | 28 | |||||
Item 11. | 33 | |||||
Item 12. | 34 | |||||
Item 13. | 35 | |||||
Item 14. | 37 | |||||
Item 15. | 39 | |||||
Item 16. | 39 |
• | our ability to select an appropriate target business or businesses; |
• | our ability to complete our initial business combination; |
• | our expectations around the performance of the prospective target business or businesses; |
• | our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination; |
• | our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination; |
• | our potential ability to obtain additional financing to complete our initial business combination; |
• | our pool of prospective target businesses; |
• | the ability of our officers and directors to generate a number of potential business combination opportunities; |
• | our public securities’ potential liquidity and trading; |
• | the lack of a market for our securities; |
• | the use of proceeds not held in the trust account or available to us from interest income on the trust account balance; |
• | the trust account not being subject to claims of third parties; or |
• | our financial performance. |
• | “anchor investor” are to a qualified institutional buyer who purchased units (as defined below) in the initial public offering (as defined below) and membership interest in our sponsor (as defined below) pursuant to the letter agreement attached as Exhibit 99.3; |
• | “anchor founder shares” are to the founder shares (as defined below) purchased by the anchor investor; |
• | “anchor warrants” are to the private placement warrants (as defined below) purchased by the anchor investor; |
• | “board of directors” or “board” are to the board of directors of the Company; |
• | “Class A common stock” are to shares of the Class A common stock of the Company, par value $0.0001 per share; |
• | “Class B common stock” are to shares of the Class B common stock of the Company, par value $0.0001 per share; |
• | “common stock” are to our Class A common stock and our Class B common stock, collectively; |
• | “Continental” are to Continental Stock Transfer & Trust Company, trustee of our trust account (as defined below) and warrant |
• | “DGCL” are to the Delaware General Corporation Law. |
• | “DWAC System” are to the Depository Trust Company’s Deposit/Withdrawal At Custodian System; |
• | “Exchange Act ” are to the Securities Exchange Act of 1934, as amended; |
• | “equity-linked securities” are to any securities of our Company that are convertible into or exchangeable or exercisable for, common stock of our Company; |
• | “Extension Period” refers to any extended time that the Company has to consummate a business combination beyond 24 months as a result of a stockholder vote to amend our amended and restated certificate of incorporation; |
• | “founder shares” are to shares of our Class B common stock purchased by our sponsor in a private placement prior to our initial public offering and the shares of our Class A common stock issued upon the conversion thereof as described herein; |
• | “GAAP” are to the accounting principles generally accepted in the United States of America; |
• | “Haymaker I” are to Haymaker Acquisition Corp.; |
• | “Haymaker II” are to Haymaker Acquisition Corp. II; |
• | “Haymaker III” are to Haymaker Acquisition Corp. III; |
• | “IFRS” are to the International Financial Reporting Standards, as issued by the International Accounting Standards Board; |
• | “initial business combination” are to a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses; |
• | “initial public offering” are to the initial public offering that was consummated by the Company on January 12, 2021; |
• | “initial stockholders” are to holders of our founder shares prior to our initial public offering; |
• | “Investment Company Act” are to the Investment Company Act of 1940, as amended; |
• | “JOBS Act” are to the Jumpstart Our Business Startups Act of 2012; |
• | “Marcum” are to Marcum LLP, our independent registered public accounting firm; |
• | “management” or our “management team” are to our officers and directors; |
• | “Nasdaq” are to the Nasdaq Stock Market; |
• | “PCAOB” are to the Public Company Accounting Oversight Board (United States); |
• | “private placement warrants” are to the warrants issued to our sponsor in a private placement simultaneously with the closing of our initial public offering; |
• | “public shares” are to shares of our Class A common stock sold as part of the units in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market); |
• | “public stockholders” are to the holders of our public shares, including our initial stockholders and members of our management team to the extent our initial stockholders and/or members of our management team purchase public shares, provided that each initial stockholder’s and member of our management team’s status as a “public stockholder” shall only exist with respect to such public shares; |
• | “public warrants” are to (1) our redeemable warrants sold as part of the units in our initial public offering (whether they were purchased in our initial public offering or thereafter in the open market) and (2) any private placement warrants or warrants issued upon conversion of working capital loans that are sold to third parties that are not initial purchasers or permitted transferees following the consummation of our initial business combination; |
• | “Registration Statement” are to the Registration Statement on Form S-1 filed with the SEC on October 2, 2020 (File Nos. 333-249278 and 333-251593), as amended; |
• | “Report” are to this Annual Report on Form 10-K for the fiscal year ended December 31, 2021; |
• | “Sarbanes-Oxley Act” are to the Sarbanes-Oxley Act of 2002; |
• | “SEC” are to the U.S. Securities and Exchange Commission; |
• | “Securities Act” are to the Securities Act of 1933, as amended; |
• | “specified future issuance” are to an issuance of a class of equity or equity-linked securities to certain purchasers, which may include affiliates of our management team, that we may determine to make in connection with financing our initial business combination; |
• | “sponsor” are to Tastemaker Sponsor LLC, a Delaware limited liability company and an affiliate of certain members of our management team; |
• | “trust account” are to the trust account in which an amount of $278,760,000 ($10.10 per unit) from the net proceeds of the sale of the units and private placement warrants in the initial public offering was placed following the closing of the initial public offering; |
• | “units” are to the units sold in our initial public offering, which consist of one public share and one-half of one public warrant; |
• | “warrants” are to our redeemable warrants, which includes the public warrants as well as the private placement warrants; and |
• | “we,” “us,” “our,” “Company,” or “our Company” are to Tastemaker Acquisition Corp |
ITEM 1. |
BUSINESS. |
• | extensive experience in both operating and investing in public and private companies in the Target Sectors; |
• | track records in marketing and growing companies through driving profitable revenue and unit growth, optimizing unit economics, employing omni-channel business models, leveraging franchising, increasing brand awareness and customer engagement, and deploying technology; |
• | longstanding relationships with a wide variety of potential sellers, including founders, financial sponsors and management teams of potential target companies; and |
• | experience in sourcing, structuring, acquiring, operating, developing, growing, financing and selling businesses under varying economic and financial market conditions. |
• | directly identifying attractive growth-oriented companies and potentially undervalued opportunities through primary research into industries and companies; |
• | receiving information from our relationships and contacts about potentially attractive situations; |
• | contact from securities broker-dealers’ research, sales, trading or investment banking department offering or identifying businesses seeking a combination or added value that matches our strengths; or |
• | inbound opportunities from a company or existing stakeholders seeking a combination, including sales, mergers and corporate divestitures. |
• | have strong and differentiated brands, strong unit economics and market share, exceptional management teams and significant growth prospects; |
• | would benefit from our extensive networks and insights within the Target Sectors, and leverage our transaction and capital markets expertise; |
• | are fundamentally sound companies that may benefit from capital and public company catalysts, or that may be currently underperforming their potential for various reasons and offer a compelling value; |
• | can benefit from a strategic partnership with our management team to achieve long-term strategic success and operational excellence; |
• | exhibit unrecognized value or other characteristics, desirable returns on capital, and a need for capital or recapitalization to achieve the given company’s growth strategy; |
• | will offer an attractive risk-adjusted return for our shareholders; and |
• | will have an expected enterprise value, at the time of our initial business combination, of approximately $400 million to $1 billion. |
• | solely dependent upon the performance of a single business, property or asset; or |
• | dependent upon the development or market acceptance of a single or limited number of products, processes or services. |
Type of Transaction |
Whether Stockholder Approval is Required | |
Purchase of assets | No | |
Purchase of stock of target not involving a merger with the company | No | |
Merger of target into a subsidiary of the company | No | |
Merger of the company with a target | Yes |
• | we issue shares of Class A common stock that will be equal to or in excess of 20% of the number of shares of our Class A common stock then outstanding; |
• | any of our directors, officers or substantial stockholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets to be acquired or otherwise and the present or potential issuance of common stock could result in an increase in outstanding common shares or voting power of 5% or more; or |
• | the issuance or potential issuance of common stock will result in our undergoing a change of control. |
• | the timing of the transaction, including in the event we determine stockholder approval would require additional time and there is either not enough time to seek stockholder approval or doing so would place the company at a disadvantage in the transaction or result in other additional burdens on the company; |
• | the expected cost of holding a stockholder vote; |
• | the risk that the stockholders would fail to approve the proposed business combination; |
• | other time and budget constraints of the company; and |
• | additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to stockholders. |
• | conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers, and |
• | file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies. |
• | conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules, and |
• | file proxy materials with the SEC. |
• | We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. |
• | Our public stockholders may not be afforded an opportunity to vote on our initial proposed business combination, which means we may complete our initial business combination even though a majority of our public stockholders do not support such a combination. |
• | If we seek stockholder approval of our initial business combination, our sponsor, officers and directors have agreed to vote in favor of such initial business combination, regardless of how our public stockholders vote. |
• | If we seek stockholder approval of our initial business combination and we do not conduct redemptions pursuant to the tender offer rules, and if you or a “group” of stockholders are deemed to hold in excess of 15% of our Class A common stock, you will lose the ability to redeem all such shares in excess of 15% of our Class A common stock. |
• | Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. |
• | Our sponsor contributed $25,000, or approximately $0.004 per founder share, and, accordingly, you will experience immediate and substantial dilution from the purchase of our Class A common stock. |
• | Your only opportunity to affect the investment decision regarding a potential business combination will be limited to the exercise of your right to redeem your shares from us for cash, unless we seek stockholder approval of the business combination. |
• | The ability of our public stockholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with a target. |
• | The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares may not allow us to complete the most desirable business combination or optimize our capital structure. |
• | The ability of our public stockholders to exercise redemption rights with respect to a large number of our shares could increase the probability that our initial business combination would be unsuccessful and that you would have to wait for liquidation in order to redeem your stock. |
• | The requirement that we complete our initial business combination within the prescribed time frame may give potential target businesses leverage over us in negotiating a business combination and may limit the time we have in which to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that would produce value for our stockholders. |
• | We may not be able to complete our initial business combination within the prescribed time frame, in which case we would cease all operations except for the purpose of winding up and we would redeem our public shares and liquidate, in which case our public stockholders may only receive $10.10 per share, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | If we seek stockholder approval of our initial business combination, our sponsor, directors, officers or their affiliates may enter into certain transactions, including purchasing shares or warrants from the public, which may influence the outcome of a proposed business combination and reduce the public “float” of our securities. |
• | If a stockholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for tendering its shares, such shares may not be redeemed. |
• | Our search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially adversely affected by the recent coronavirus (COVID-19) outbreak and other events and the status of debt and equity markets. |
• | As the number of special purpose acquisition companies evaluating targets increases, attractive targets may become scarcer and there may be more competition for attractive targets. This could increase the cost of our initial business combination and could even result in our inability to find a target or to consummate an initial business combination. |
• | You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. To liquidate your investment, therefore, you may be forced to sell your public shares or warrants, potentially at a loss. |
• | You will not be entitled to protections normally afforded to investors of many other blank check companies. |
• | Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we are unable to complete our initial business combination, our public stockholders may receive only approximately $10.10 per share on our redemption of our public shares, or less than such amount in certain circumstances, and our warrants will expire worthless. |
• | Our expectations around the performance of a prospective target business or businesses may not be realized. |
• | We may not be successful in retaining or recruiting required officers, key employees or directors following our initial business combination. |
• | Our officers and directors may have difficulties allocating their time between the Company and other businesses and may potentially have conflicts of interest with our business or in approving our initial business combination. |
• | We may not be able to obtain additional financing to complete our initial business combination or reduce the number of shareholders requesting redemption. |
• | We may issue our shares to investors in connection with our initial business combination at a price that is less than the prevailing market price of our shares at that time. |
• | Trust account funds may not be protected against third party claims or bankruptcy. |
• | An active market for our public securities’ may not develop and you will have limited liquidity and trading; |
• | The availability to us of funds from interest income on the trust account balance may be insufficient to operate our business prior to the business combination. |
• | Our financial performance following a business combination with an entity may be negatively affected by their lack an established record of revenue, cash flows and experienced management. |
• | Changes in the market for directors and officers liability insurance could make it more difficult and more expensive for us to negotiate and complete an initial business combination. |
• | We may attempt to simultaneously complete business combinations with multiple prospective targets, which may hinder our ability to complete our initial business combination and give rise to increased costs and risks that could negatively impact our operations and profitability. |
• | We may engage one or more of our underwriters or one of their respective affiliates to provide additional services to us after the initial public offering, which may include acting as a financial advisor in connection with an initial business combination or as placement agent in connection with a related financing transaction. Our underwriters are entitled to receive deferred underwriting commissions that will be released from the trust account only upon a completion of an initial business combination. These financial incentives may cause them to have potential conflicts of interest in rendering any such additional services to us after the initial public offering, including, for example, in connection with the sourcing and consummation of an initial business combination. |
• | We may attempt to complete our initial business combination with a private company about which little information is available, which may result in a business combination with a company that is not as profitable as we suspected, if at all. |
• | Our warrants are accounted for as derivative liabilities and are recorded at fair value upon issuance with changes in fair value each period reported in earnings, which may have an adverse effect on the market price of our common stock or may make it more difficult for us to consummate an initial business combination. |
• | Since our initial stockholders will lose their entire investment in us if our initial business combination is not completed (other than with respect to any public shares they may acquire during or after this offering), and because our sponsor, officers and directors may profit substantially even under circumstances in which our public stockholders would experience losses in connection with their investment, a conflict of interest may arise in determining whether a particular business combination target is appropriate for our initial business combination. |
• | Changes in laws or regulations or how such laws or regulations are interpreted or applied, or a failure to comply with any laws or regulations, may adversely affect our business, including our ability to negotiate and complete our initial business combination, and results of operations. |
• | The value of the founder shares following completion of our initial business combination is likely to be substantially higher than the nominal price paid for them, even if the trading price of our common stock at such time is substantially less than $10.00 per share. |
• | Resources could be wasted in researching acquisitions that are not completed, which could materially adversely affect subsequent attempts to locate and acquire or merge with another business. If we have not completed our initial business combination within the required time period, our public stockholders may receive only approximately $10.00 per share, or less than such amount in certain circumstances, on the liquidation of our trust account and our warrants will expire worthless. |
• | We have identified a material weakness in our internal control over financial reporting as of December 31, 2021. If we are unable to maintain an effective system of internal control over financial reporting, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our business and operating results. |
• | If the funds held outside of our trust account are insufficient to allow us to operate until at least January 12, 2023, our ability to fund our search for a target business or businesses or complete an initial business combination may be adversely affected. |
• | Our independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about our ability to continue as a going concern, since we will cease all operations except for the purpose of liquidating if we are unable to complete an initial business combination by January 12, 2023. |
• | Our ability to identify a target and to consummate an initial business combination may be adversely affected by economic uncertainty and volatility in the financial markets, including as a result of the military conflict in Ukraine. |
• | may significantly dilute the equity interest of investors in this offering, which dilution would increase if the anti-dilution provisions in the Class B common stock resulted in the issuance of Class A shares on a greater than one-to-one |
• | may subordinate the rights of holders of common stock if preferred stock is issued with rights senior to those afforded our common stock; |
• | could cause a change of control if a substantial number of shares of our common stock is issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; |
• | may have the effect of delaying or preventing a change of control of us by diluting the stock ownership or voting rights of a person seeking to obtain control of us; |
• | may adversely affect prevailing market prices for our units, Class A common stock and/or warrants; and |
• | may not result in adjustment to the exercise price of our warrants. |
• | default and foreclosure on our assets if our operating revenues after an initial business combination are insufficient to repay our debt obligations; |
• | acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; |
• | our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; |
• | our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; |
• | our inability to pay dividends on our common stock; |
• | using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our common stock if declared, our ability to pay expenses, make capital expenditures and acquisitions, and fund other general corporate purposes; |
• | limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; |
• | increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; |
• | limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, and execution of our strategy; and |
• | other disadvantages compared to our competitors who have less debt. |
(1) | pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of our company, |
(2) | provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors, and |
(3) | provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements. |
Name |
Age |
Title | ||
David Pace | 62 | Co-Chief Executive Officer and Director | ||
Andrew Pforzheimer | 60 | Co-Chief Executive Officer and Director | ||
Gregory Golkin | 37 | President and Director | ||
Christopher Bradley | 44 | Chief Financial Officer and Secretary | ||
Daniel Fleischmann | 33 | Chief Strategy Officer | ||
Hal Rosser | 72 | Director | ||
Rick Federico | 67 | Director | ||
Starlette Johnson | 58 | Director | ||
Andrew Heyer | 64 | Director |
• | the appointment, compensation, retention, replacement, and oversight of the work of the independent registered public accounting firm engaged by us; |
• | pre-approving all audit and permitted non-audit services to be provided by the independent registered public accounting firm engaged by us, and establishing pre-approval policies and procedures; |
• | setting clear hiring policies for employees or former employees of the independent registered public accounting firm, including but not limited to, as required by applicable laws and regulations; |
• | setting clear policies for audit partner rotation in compliance with applicable laws and regulations; |
• | obtaining and reviewing a report, at least annually, from the independent registered public accounting firm describing (i) the independent registered public accounting firm’s internal quality-control procedures, (ii) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues and (iii) all relationships between the independent registered public accounting firm and us to assess the independent registered public accounting firm’s independence; |
• | reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of RegulationS-K promulgated by the SEC prior to us entering into such transaction; and |
• | reviewing with management, the independent registered public accounting firm, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. |
• | reviewing and approving on an annual basis the corporate goals and objectives relevant to our co-Chief Executive Officers’ compensation, if any is paid by us, evaluating our co-Chief Executive Officers’ performance in light of such goals and objectives and determining and approving the remuneration (if any) of our co-Chief Executive Officers based on such evaluation; |
• | reviewing and approving on an annual basis the compensation, if any is paid by us, of all of our other officers; |
• | reviewing on an annual basis our executive compensation policies and plans; |
• | implementing and administering our incentive compensation equity-based remuneration plans; |
• | assisting management in complying with our proxy statement and annual report disclosure requirements; |
• | approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; |
• | if required, producing a report on executive compensation to be included in our annual proxy statement; and |
• | reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. |
• | each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock; |
• | each of our executive officers and directors that beneficially owns shares of our common stock; and |
• | all our executive officers and directors as a group. |
Name and Address of Beneficial Owner (1) |
Number of Shares Beneficially Owned (2) |
Approximate Percentage of Outstanding Common Stock |
||||||
Tastemaker Sponsor LLC(3) |
6,900,000 | 20.0 | % | |||||
David Pace (3) |
6,900,000 | 20.0 | % | |||||
Andrew Pforzheimer (3) |
6,900,000 | 20.0 | % | |||||
Gregory Golkin (3) |
6,900,000 | 20.0 | % | |||||
Christopher Bradley |
— | — | ||||||
Daniel Fleischmann |
— | — | ||||||
Hal Rosser |
— | — | ||||||
Rick Federico |
— | — | ||||||
Starlette Johnson |
— | — | ||||||
Andrew Heyer |
— | — | ||||||
All executive officers and directors as a group (nine individuals) |
6,900,000 | 20.0 | % | |||||
Karpus Investment Management (4) |
1,968,922 | 5.7 | % |
(1) | Unless otherwise noted, the business address of each of the following entities or individuals is 501 Madison Avenue, 12 th Floor, New York NY 10022. |
(2) | Interests shown consist solely of founder shares, classified as shares of Class B common stock. The founder shares will convert into shares of Class A common stock at the time of our initial business combination, or earlier at the option of the holder, on a one-for-one |
(3) | Our sponsor is the record holder of such shares. Dave Pace and Andy Pforzheimer, our co-Chief Executive Officers, and Greg Golkin, our President, are managing members of our sponsor. Consequently, Messrs. Pace, Pforzheimer and Golkin may be deemed to beneficially own the shares held by our sponsor and share voting and dispositive control over such securities. Each of Messrs. Pace, Pforzheimer and Golkin disclaims beneficial ownership of any shares other than to the extent he may have a pecuniary interest therein, directly or indirectly. Each of our other officers and directors are non-managing members of our sponsor. |
(4) | Based on a Schedule 13G filed with the SEC on February 14, 2022 by Karpus Management, Inc., d/b/a Karpus Investment Management (“Karpus”), which is a registered investment adviser under Section 203 of the Investment Advisers Act of 1940. Karpus is controlled by City of London Investment Group plc (“CLIG”), which is listed on the London Stock Exchange. However, in accordance with SEC Release No. 34-39538 (January 12, 1998), effective informational barriers have been established between Karpus and CLIG such that voting and investment power over the subject securities is exercised by Karpus independently of CLIG, and, accordingly, attribution of beneficial ownership is not required between Karpus and CLIG. The shares of Class A common stock reported in the Schedule 13G are owned directly by the accounts managed by Karpus. Karpus beneficially owns 1,968,922 shares of Class A common stock, though has the power to vote or direct the vote of 1,818,922 shares. The address of the principal business office of Karpus is 501 Madison Avenue, Floor 12, New York, NY 10019. |
Year Ended December 31, 2021 |
Year Ended December 31, 2020 |
|||||||
Audit Fees |
$ | 155,025 | $ | 57,500 | ||||
Audit Related Fees |
— | — | ||||||
Tax Fees |
8,500 | 7,210 | ||||||
All Other Fees |
— | — | ||||||
Total |
$ | 163,525 | $ | 64,710 |
(a) |
The following documents are filed as part of this Report: |
(1) |
Financial Statements |
Page |
||||
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
(2) |
Financial Statement Schedules |
(3) |
Exhibits |
Exhibit |
Description | |
1.1 |
||
3.1 |
||
3.2 |
||
4.1 |
||
4.2 |
||
4.3 |
||
4.4 |
||
4.5 |
||
10.1 |
||
10.2 |
||
10.3 |
||
10.4 |
||
10.5 |
||
10.6 |
||
10.7 |
||
10.8 |
||
10.9 |
||
14 |
||
31.1* |
||
31.2* |
Exhibit |
Description | |
31.3* |
||
32.1** |
||
99.1 |
||
99.2 |
||
99.3 |
||
101.INS* |
Inline XBRL Instance Document. | |
101.SCH* |
Inline XBRL Taxonomy Extension Schema. | |
101.CAL* |
Inline XBRL Taxonomy Extension Calculation Linkbase. | |
101.LAB* |
Inline XBRL Taxonomy Extension Label Linkbase. | |
101.PRE* |
Inline XBRL Taxonomy Extension Presentation Linkbase. | |
101.DEF* |
Inline XBRL Taxonomy Extension Definition Document. | |
104 |
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
* |
Filed herewith. |
** |
Furnished herewith. |
F-2 |
||||
F-3 |
||||
F-4 |
||||
F-5 |
||||
F-6 |
||||
F-7 |
December 31, 2021 |
December 31, 2020 |
|||||||
Assets: |
||||||||
Current assets: |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses and other |
||||||||
Total current assets |
||||||||
Deferred offering costs |
||||||||
Investments held in Trust Account |
||||||||
Total Assets |
$ |
$ |
||||||
Liabilities and Stockholders’ Deficit: |
||||||||
Current liabilities: |
||||||||
Accounts payable |
$ | $ | ||||||
Accrued expenses |
||||||||
Franchise tax payable |
||||||||
Promissory note—related party |
||||||||
Total current liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
Warrant liabilities |
||||||||
Total Liabilities |
||||||||
Commitments and Contingencies (Note 6) |
||||||||
Class A common stock, $ |
||||||||
Stockholders’ Deficit: |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
||||||||
Class B common stock, $ at December 31, 2021 and 2020 |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
Total Stockholders’ Deficit |
( |
) | ( |
) | ||||
Total Liabilities and Stockholders’ Deficit |
$ |
$ |
||||||
For the year ended December 31, 2021 |
For the period from August 10, 2020 (inception) through December 31, 2020 |
|||||||
Operating and formation costs |
$ | $ | ||||||
Franchise tax expense |
||||||||
|
|
|
|
|||||
Loss from operations |
( |
) | ( |
) | ||||
Interest income |
||||||||
Expensed offering costs |
( |
) | ||||||
Change in fair value of warrant liabilities |
||||||||
|
|
|
|
|||||
Net income (loss) |
$ | $ | ( |
) | ||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding, Class A Common Stock |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class A Common Stock |
$ | $ | ||||||
|
|
|
|
|||||
Basic and diluted weighted average shares outstanding, Class B Common Stock |
||||||||
|
|
|
|
|||||
Basic and diluted net income (loss) per share, Class B Common Stock |
$ | $ | ( |
) | ||||
|
|
|
|
Common Stock |
||||||||||||||||||||||||||||||||
Class A |
|
Class B |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
|||||||||||||||||||||||||||
Shares |
Amount |
|
Shares |
Amount |
||||||||||||||||||||||||||||
Balance—August 10, 2020 (Inception) |
$ | $ | $ | $ | $ | |||||||||||||||||||||||||||
Sale of Class B common stock to Sponsor |
— | — | — | |||||||||||||||||||||||||||||
Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance –December 31, 2020 |
( |
) |
( |
) | ||||||||||||||||||||||||||||
Excess of cash received over fair value of private placement warrant s |
— |
— |
— |
— |
||||||||||||||||||||||||||||
Accretion of Class A ordinary shares to redemption amount |
— | — | — | ( |
) | ( |
) |
( |
) | |||||||||||||||||||||||
Net Income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Balance –December 31, 2021 |
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the year ended December 31, 2021 |
For the period from August 10, 2020 (inception) through December 31, 2020 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income (loss) |
$ | $ | ( |
) | ||||
Adjustments to reconcile net income ( loss) to net cash used in operating activities: |
||||||||
Expensed offering costs |
— | |||||||
Interest income |
( |
) | — | |||||
Change in fair value of warrant liabilities |
( |
) | — | |||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses and other |
( |
) | — | |||||
Accounts payable |
— | |||||||
Accrued expenses |
— | |||||||
Franchise tax payable |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Cash deposited in Trust Account |
( |
) | — | |||||
|
|
|
|
|||||
Net cash used in investing activities |
( |
) |
— |
|||||
|
|
|
|
|||||
Cash Flows from Financing Activities: |
||||||||
Proceeds from issuance of Class B common stock to Sponsor |
— | |||||||
Proceeds from issuance of promissory note—related party |
— | |||||||
Repayment of promissory note—related party |
( |
) | — | |||||
Proceeds from initial public offering, net of underwriter’s discount paid |
— | |||||||
Proceeds from sale of private placement warrants |
— | |||||||
Offering costs paid |
( |
) | ( |
) | ||||
Reimbursed offering costs |
||||||||
|
|
|
|
|||||
Net cash provided by financing activities |
||||||||
|
|
|
|
|||||
Net change in cash |
||||||||
Cash—beginning of period |
— | |||||||
|
|
|
|
|||||
Cash—end of period |
$ |
$ |
||||||
|
|
|
|
|||||
Supplemental disclosure of noncash investing and financing activities: |
||||||||
Accretion of Class A common stock subject to redemption to redemption value |
$ | $ | — | |||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | $ | — | |||||
|
|
|
|
|||||
Reclassification of deferred offering costs to equity upon completion of the initial public offering |
$ | $ | ||||||
|
|
|
|
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Issuance costs allocated to Class A common stock |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
|
|
|||
Class A common stock subject to possible redemption |
$ |
|||
|
|
For the Year ended December 31, 2021 |
For the Period from August 10, 2020 (inception) Through December 31, 2020 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Basic and diluted net income (loss) per share: |
||||||||||||||||
Numerator: |
||||||||||||||||
Net income (loss) |
$ | $ | $ | $ | ( |
) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Denominator: |
||||||||||||||||
Basic and diluted weighted average shares outstanding |
||||||||||||||||
Basic and diluted net income (loss) per share |
$ | $ | $ | ( |
) |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the closing price of the common stock equals or exceeds $ |
2021 |
2020 |
|||||||
Deferred tax assets: |
||||||||
Start-up costs |
$ |
$ | ||||||
Net operating loss carryforwards |
||||||||
Total deferred tax assets |
||||||||
Valuation allowance |
( |
) |
( |
) | ||||
Deferred tax assets, net of allowance |
$ |
— |
$ | — | ||||
Federal |
||||
Current |
$ | |||
Deferred |
( |
) | ||
State |
||||
Current |
||||
Deferred |
||||
Change in valuation allowance |
||||
Income tax provision |
$ | — | ||
Statutory federal income tax rate |
% | |||
State taxes, net of federal tax benefit |
% | |||
Change in fair value of derivative warrant liabilities |
( |
)% | ||
Non-deductible transaction costs |
% | |||
Change in valuation allowance |
% | |||
Income tax provision |
% | |||
Description |
Amount at Fair Value |
Level 1 |
Level 2 |
Level 3 |
||||||||||||
December 31, 2021 |
||||||||||||||||
Assets |
||||||||||||||||
Investments held in Trust Account |
$ | $ | $ | — | $ | — | ||||||||||
Liabilities |
||||||||||||||||
Warrant liability – Public Warrants |
$ | $ | $ | — | $ | — | ||||||||||
Warrant liability – Private Placement Warrants |
$ | $ | $ | — |
At January 12, 2021 (Initial Measurement) |
||||
Stock price |
$ | |||
Strike price |
$ | |||
Probability of completing a Business Combination |
% | |||
Expected life of the option to convert (in years) |
||||
Volatility |
| |||
Risk-free rate |
% | |||
Fair value of warrants |
$ |
At January 12, 2021 (Initial Measurement) |
As of December 31, 2021 |
|||||||
Stock price |
$ | $ | ||||||
Strike price |
$ | $ | ||||||
Probability of completing a Business Combination |
% | % | ||||||
Dividend yield |
— | % | — | % | ||||
Remaining term (in years) |
||||||||
Volatility |
% | % | ||||||
Risk-free rate |
% | % | ||||||
Fair value of warrants |
$ | $ |
Fair value as of December 31, 2020 |
$ |
— |
||
Initial measurement at January 12, 2021 |
||||
Transfer of Public Warrants to Level 1 measurement |
( |
) | ||
Transfer of Private Placement Warrants to Level 2 measurement |
|
|
( |
) |
Change in fair value |
( |
) | ||
|
|
|||
Fair value as of December 31, 202 1 |
$ | — |
||
|
|
Tastemaker Acquisition Corp. | ||||||
Dated: March 24, 2022 |
By: |
/s/ David Pace | ||||
David Pace | ||||||
Co-Chief |
Signature |
Title |
Date | ||
/s/ David Pace |
Co-Chief |
March 24, 2022 | ||
David Pace |
(Principal Executive Officer) |
|||
/s/ Andrew Pforzheimer |
Co-Chief |
March 24, 2022 | ||
Andrew Pforzheimer |
(Principal Executive Officer) |
|||
/s/ Christopher Bradley |
Chief Financial Officer |
March 24, 2022 | ||
Christopher Bradley |
(Principal Financial and Accounting Officer) |
|||
/s/ Gregory Golkin |
President and Director |
March 24, 2022 | ||
Gregory Golkin |
||||
/s/ Hal Rosser |
Director |
March 24, 2022 | ||
Hal Rosser |
||||
/s/ Rick Federico |
Director |
March 24, 2022 | ||
Rick Federico |
||||
/s/ Starlette Johnson |
Director |
March 24, 2022 | ||
Starlette Johnson |
||||
/s/ Andrew Heyer |
Director |
March 24, 2022 | ||
Andrew Heyer |